产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1431697-74-3

中文名称

CAL-130

英文名称

CAL-130

别名

CAL-130 | 1431697-74-3 | 2-[(1S)-1-[(2-amino-7H-purin-6-yl)amino]ethyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one | HY-16122A | NCGC00378554-01 | 2-[(1S)-1-[(2-Amino-9H-purin-6-yl)amino]ethyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone | SCHEMBL172

标准英文名

(S)-2-(1-((2-amino-7H-purin-6-yl)amino)ethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one

分子式

C23H22N8O

分子量

426.48

精确分子量

426.19

SMILES

O=C1N(C2=CC=CC=C2C)C([C@H](C)NC3=C4N=CNC4=NC(N)=N3)=NC5=C1C(C)=CC=C5

标准SMILES

C[C@H](NC1N=C(N)N=C2NC=NC2=1)C1=NC2C=CC=C(C)C=2C(=O)N1C1=CC=CC=C1C

用途

CAL-130 is a potent and selective inhibitor of PI3Kδ and PI3Kγ, with IC50 values of 1.3 nM and 6.1 nM, respectively, and shows significantly less activity against PI3Kβ (IC50 = 56 nM) and PI3Kα (IC50 = 115 nM). It does not inhibit other critical intracellular signaling pathways such as p38 MAPK or insulin receptor tyrosine kinase. In vivo, CAL-130 demonstrates significant therapeutic efficacy in a mouse model of T-cell acute lymphoblastic leukemia (T-ALL), markedly extending median survival (45 days vs. 7.5 days in controls) following short-term oral administration (10 mg/kg every 8 hours for 7 days).

InChIKey

PUYVJBBSBPUKBT-AWEZNQCLSA-N

安全信息

SureRoute逆合成路线

1.  1431697-74-3 逆合成路线 1

—
—
ACBFEI078
1431697-74-3
来源: SureRoute

2.  1431697-74-3 逆合成路线 2

—
—
ACIGFL096
10310-21-1
ACBFEI078
1431697-74-3
来源: SureRoute

3.  1431697-74-3 逆合成路线 3

—
—
—
—
ACBFEI078
1431697-74-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手